Q4 2024 Earnings Call Transcript March 17, 2025 Quanterix Corporation misses on earnings expectations. Reported EPS is $-0.3 ...

Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic ...

NfL was assessed using the ultrasensitive Simoa and microfluidic Ella platforms and with Lumipulse and Elecsys assays, recently set up on clinical-grade platforms. Serum GFAP and pTau181 were also ...

A factor VIII assay tests for a protein involved in blood clotting. If you produce less of this protein, it may indicate a bleeding disorder. Some people may also have high levels of this ...

Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, ...

Department of Neurology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei 100, Taiwan Institute of Molecular Medicine, College of Medicine, National Taiwan ...

One of these was a new commercially available Simoa assay for plasma p-tau217 (ALZpath).21 CSF p-tau217 was measured with a Lumipulse immunoassay (Fujirebio, Belgium) for this research study, in ...

A wide selection of Simoa® assay kits is offered to assess important biomarkers with far higher sensitivity than conventional immunoassay techniques. Convenient: Benchtop instrument with built-in ...

The system detected simultaneously 10 cytokines in a multiplex assay with Simoa Corplex Cytokine Panel 1 10-Plex Kit (REF: 85-0329, Quanterix). The assay was performed according to the manufacturer’s ...

The test is powered by the Simoa ® (single-molecule assay) technology of Quanterix Corp. “The clinical availability of the ALZpath Dx test is significant as it provides a more scalable, more ...